Sort
39,280 grants matching “leukemia”
EZH2 in cancer biology and novel inhibitors
$536,827Jun Qi · Dana-Farber Cancer Inst · R01 · FY2021 · CA
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes
$536,812Qisheng Zhang · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
JAK Inhibition in Down Syndrome
$536,728Joaquin M. Espinosa · University Of Colorado Denver · R33 · FY2023 · AR
LEARNING IMPAIRMENTS AMONG SURVIVORS OF CHILDHOOD CANCER
$536,727St. Jude Children'S Research Hospital · R01 · FY2000 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2015 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2016 · CA
Targeted Therapy for Lymphoid Malignancies
$536,708John C Byrd · Ohio State University · R01 · FY2017 · CA
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC
$536,596Francis X McCormack · University Of Cincinnati · U01 · FY2021 · HL
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
$536,570John C Byrd · Ohio State University · R01 · FY2016 · CA
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
$536,535Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Protein Aggregation in Hematopoietic Stem Cells
$536,468Robert A.j. Signer · University Of California, San Diego · R01 · FY2025 · HL
The Role of PHF6 in HSC self-renewal and myeloid expansion
$536,436Vikram R. Paralkar · University Of Pennsylvania · R01 · FY2021 · HL
MLL FUSION GENES IN MYELOID AND LYMPHOID LEUKEMIAS
$536,418Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
$536,367Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$536,357Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$536,356Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$536,307Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$536,307Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Behavioral Science Core
$536,191Alan S Wayne · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
$536,090Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Glia maturation factor-gamma modulation of signaling pathways in macrophages
$535,837Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
PolQ as a novel therapeutic target in AML
$535,835Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2022 · CA
TCR engineered T cell therapies for hematologic malignancies
$535,786Kazusa Ishii · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$535,736Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2025 · CA
Escape from CAR T surveillance through lineage plasticity
$535,637Patricia A Ernst · University Of Colorado Denver · R01 · FY2024 · CA